SLC35F2-AMPD3 Fusion FISH Probe
The SLC35F2-AMPD3 Fusion FISH Probe is used to confirm a fusion of the SLC35F2 and AMPD3 genes. The fusion of the SLC35F2 and AMPD3 genes has been associated with Pancreatic Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC35F2-AMPD3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC35F2-AMPD3-20-AQAQ | 20 (40 μL) | 200 μL |
|
AMPD3 Gene Summary
This gene encodes a member of the AMP deaminase gene family. The encoded protein is a highly regulated enzyme that catalyzes the hydrolytic deamination of adenosine monophosphate to inosine monophosphate, a branch point in the adenylate catabolic pathway. This gene encodes the erythrocyte (E) isoforms, whereas other family members encode isoforms that predominate in muscle (M) and liver (L) cells. Mutations in this gene lead to the clinically asymptomatic, autosomal recessive condition erythrocyte AMP deaminase deficiency. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. [provided by RefSeq, Jul 2008]
Gene Name: Adenosine Monophosphate Deaminase 3
Chromosome: CHR11: 10471867 -10529126
Locus: 11p15.4
SLC35F2 Gene Summary
The Solute Carrier Family 35 Member F2 (SLC35F2) gene is located on chr11 :107661716-107729914 at 11q22.3.
Gene Name: Solute Carrier Family 35 Member F2
Chromosome: CHR11: 107661716 -107729914
Locus: 11q22.3
Gene Diseases
The SLC35F2 AMPD3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Pancreatic Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|